- Participants in the semaglutide group achieved a weight loss of at least 5%, 10%, or 15%, and improvements in secondary endpoints, such as waist circumference, blood pressure, and lipid levels, compared to the placebo group
Heres What Might Be Going On Get more of SELF's great service journalism delivered right to your inbox.
However, it remains unknown if IF has any beneficial effects in ICH
Social media amplifies the placebo effect and creates echo chambers of positive anecdotal reports. Even if the peptides are approved for compounding, without more high-quality data, experts said the risks of peptides still outweigh the potential benefits
doi: 10.1007/s42729-021-00532-x 109 VijayarenganP.MahalakshmiG
Patents are already being filed for combinations of GLP-1s with myostatin inhibitors